Table 2 Characteristics of study participants
Healthy weight IS (n = 20) | Overweight IR (n = 20) | p value | |
|---|---|---|---|
Age (years) | 63.5 ± 1.0 | 62.5 ± 1.3 | 0.57 |
Weight (kg) | 62.3 ± 2.1 | 77.6 ± 2.1 | < 0.001 |
Height (cm) | 159.9 ± 1.4 | 164.5 ± 1.2 | 0.01 |
BMI (kg/m2) | 24.3 ± 0.7 | 28.7 ± 0.7 | < 0.001 |
Waist circumference (cm) | 80.4 ± 2.2 | 93.8 ± 1.7 | < 0.001 |
Systolic blood pressure (mmHg) | 121.6 ± 3.0 | 139.2 ± 3.0 | < 0.001 |
Diastolic blood pressure (mmHg) | 67.0 ± 2.2 | 72.0 ± 2.3 | 0.09 |
Plasma glucose (mg) | 99.3 ± 1.8 | 108.6 ± 1.8 | 0.57 |
HDLc (mM) | 2.1 ± 0.1 | 1.7 ± 0.1 | < 0.01 |
Triglycerides (mM) | 0.91 ± 0.1 | 1.40 ± 0.1 | < 0.01 |
Insulin (mIU) | 5.2 ± 0.5 | 9.1 ± 0.8 | 0.01 |
Medication use (n) | |||
Aspirin | 2 | 1 | |
Statins | 0 | 3 | |
ACE inhibitor | 0 | 3 | |
α-Blocker | 0 | 1 | |
β-Blocker | 0 | 1 | |
PPIs | 0 | 1 | |
SSRIs | 1 | 2 | |